- Looking to the past eradication of diseases, a new paper argues that the global eradication of COVID-19 is possible.
- The paper quantifies the factors affecting eradicability and scores a few diseases accordingly.
- The authors of the paper hope and believe that the international disruption that COVID-19 has caused may drive the world’s governments toward a global solution.
As wealthier nations struggle to get more people to undergo vaccination, lower income nations struggle to acquire sufficient vaccine doses, and new SARS-CoV-2 variants emerge, a newly published paper states that the global eradication of COVID-19 remains possible nonetheless.
Lead author of the paper, Dr. Nick Wilson of the University of Otago in Wellington, New Zealand, pointed out to Medical News Today that skepticism regarding the paper’s conclusion is not surprising:
“[The] reaction is completely understandable at the current point in time, [but] when the plans to eradicate smallpox were announced, and there were still millions of cases globally per year, many people were also very skeptical.”
The paper cites the globally felt disruption resulting from COVID-19 as presenting an opportunity for a concerted international effort. Critical to an eradication program’s success is establishing strong vaccine coverage and staying ahead of rapidly developing variants.
The paper — entitled, “We should not dismiss the possibility of eradicating COVID-19: Comparisons with smallpox and polio” — appears in BMJ Global Health.
The metrics of optimism
The authors of the paper define eradications as the “permanent reduction to zero of the worldwide incidence of infection caused by a specific agent as a result of deliberate efforts; intervention measures are no longer needed.”
The paper presents a preliminary assessment of the eradicability of COVID-19 by comparing it with other worldwide diseases, including smallpox, which has been eradicated, and polio, for which just one of three serotypes persists.
Based on an established scoring system and additional technical, sociopolitical, and economic factors that the authors included, the study compiled a total of 17 variables relating to vaccine-preventable diseases, with a three-point relative scale for each variable. Each of the diseases received a score according to these metrics, with higher values indicating a greater chance of eradication.
COVID-19 scored as being slightly more eradicable than polio.
Smallpox was most eradicable with a score of 2.7. In comparison, COVID-19 scored 1.6, and polio scored 1.5.
Medical challenges
Dr. Robert Kim-Farley, MPH, of the University of California, Los Angeles’s Fielding School of Public Health — who was not involved in writing the article — told MNT: “The single greatest obstacle to true eradication will be achieving and sustaining the very high vaccination coverage (using a vaccine with no or extremely low infection breakthrough) needed to achieve full herd immunity, whereby transmission of COVID-19 in a community ceases.”
Although he is not giving up on achieving higher vaccination coverage through more robust international public health and social measures, Dr. Wilson said that herd immunity is not a requirement for eradication.
“Smallpox was eradicated without achieving herd immunity,” said Dr. Wilson, “but rather by targeted vaccination approaches. It is also notable that countries have also eliminated measles without (quite) achieving herd immunity, and, in fact, the whole of the Americas eliminated measles for a time.”
The paper notes that there is also a “risk of the persistence of the pandemic virus in non-human animal reservoirs,” a phenomenon that is occurring with COVID-19 in the U.S. and elsewhere.
Asked whether current animal reservoirs may doom an eradication effort, Dr. Wilson said we are not there yet.
“If we had the situation of influenza viruses (widespread in wild birds) then obviously eradication would not be feasible,” he noted.
He added that “it is possible to eradicate diseases in some wild animals — for example, eliminating rabies in wild foxes via aerial bait drops containing vaccine (as per Western Europe).”
Dr. Kim-Farley cited what he sees as the three most significant obstacles to eradication success.
Current vaccines, noted Dr. Kim-Farley, “although offering excellent protection against severe illness and death, still have some breakthrough infections that can infect others.”
Identifying cases of often-asymptomatic COVID-19 is also harder, said Dr. Kim-Farley, than it is with smallpox and measles, which “are usually always symptomatic and identifiable.”
Finally, there is “the lack of political will to apply (and the unwillingness of some persons to accept) the strict public health measures, such as required vaccination, required mask wearing, required quarantine and isolation, and required testing.”

News
How the FDA opens the door to risky chemicals in America’s food supply
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are [...]
Superbug crisis could get worse, killing nearly 40 million people by 2050
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them could increase nearly 70% by 2050, a new study projects, further showing the [...]
How Can Nanomaterials Be Programmed for Different Applications?
Nanomaterials are no longer just small—they are becoming smart. Across fields like medicine, electronics, energy, and materials science, researchers are now programming nanomaterials to behave in intentional, responsive ways. These advanced materials are designed [...]
Microplastics Are Invading Our Arteries, and It Could Be Increasing Your Risk of Stroke
Higher levels of micronanoplastics were found in carotid artery plaque, especially in people with stroke symptoms, suggesting a potential new risk factor. People with plaque buildup in the arteries of their neck have been [...]
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging [...]
Engineered extracellular vesicles facilitate delivery of advanced medicines
Graphic abstract of the development of VEDIC and VFIC systems for high efficiency intracellular protein delivery in vitro and in vivo. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59377-y. https://www.nature.com/articles/s41467-025-59377-y Researchers at Karolinska Institutet have developed a technique [...]
Brain-computer interface allows paralyzed users to customize their sense of touch
University of Pittsburgh School of Medicine scientists are one step closer to developing a brain-computer interface, or BCI, that allows people with tetraplegia to restore their lost sense of touch. While exploring a digitally [...]
Scientists Flip a Gut Virus “Kill Switch” – Expose a Hidden Threat in Antibiotic Treatment
Scientists have long known that bacteriophages, viruses that infect bacteria, live in our gut, but exactly what they do has remained elusive. Researchers developed a clever mouse model that can temporarily eliminate these phages [...]
Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressing
Background Wound healing is a complex physiological process that can be compromised by infection and impaired tissue regeneration. Conventional dressings, typically made from natural fibers such as cotton or linen, offer limited functionality. Nanofiber [...]
Global Nanomaterial Regulation: A Country-by-Country Comparison
Nanomaterials are materials with at least one dimension smaller than 100 nanometres (about 100,000 times thinner than a human hair). Because of their tiny size, they have unique properties that can be useful in [...]
Pandemic Potential: Scientists Discover 3 Hotspots of Deadly Emerging Disease in the US
Virginia Tech researchers discovered six new rodent carriers of hantavirus and identified U.S. hotspots, highlighting the virus’s adaptability and the impact of climate and ecology on its spread. Hantavirus recently drew public attention following reports [...]
Studies detail high rates of long COVID among healthcare, dental workers
Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that the percentage is much higher among healthcare workers [...]
Melting Arctic Ice May Unleash Ancient Deadly Diseases, Scientists Warn
Melting Arctic ice increases human and animal interactions, raising the risk of infectious disease spread. Researchers urge early intervention and surveillance. Climate change is opening new pathways for the spread of infectious diseases such [...]
Scientists May Have Found a Secret Weapon To Stop Pancreatic Cancer Before It Starts
Researchers at Cold Spring Harbor Laboratory have found that blocking the FGFR2 and EGFR genes can stop early-stage pancreatic cancer from progressing, offering a promising path toward prevention. Pancreatic cancer is expected to become [...]
Breakthrough Drug Restores Vision: Researchers Successfully Reverse Retinal Damage
Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one of the most important human senses, yet more than 300 million people around the world are at [...]
Differentiating cancerous and healthy cells through motion analysis
Researchers from Tokyo Metropolitan University have found that the motion of unlabeled cells can be used to tell whether they are cancerous or healthy. They observed malignant fibrosarcoma [...]